Prostate Cancer Clinical Trial

Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer

Summary

The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prostate cancer. The investigators will measure changes in serum biomarkers involved in muscle-bone crosstalk, anatomic changes in muscle and bone structure and strength that could ultimately contribute to fractures. The findings from this research will inform design of interventions to reduce falls and hip fractures in patients undergoing ADT as well as application to broader populations of at risk patients.

View Full Description

Full Description

Twenty-five men from urology clinic with prostate cancer will be recruited and enrolled prior to initiating ADT and studied at three time points. Baseline (before first does of ADT), and at approximately weeks 6 and 24 while receiving ADT for prostate cancer. Study measures will be the same during each of three data acquisition time points and include ascertainment of venous blood to determine serum biochemical markers of muscle and bone metabolic activity, MRI and CT imaging studies to assess muscle strength, volume, composition, bone volume, density and strength, and validated tests of muscle strength. Subjects will serve as their own controls.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

• Dx with prostate cancer and planned ADT therapy

Exclusion Criteria:

Contraindication to MRI
Limited life expectancy
Inability to participate in exercise testing
Severe functional impairment
Chronic kidney disease 4 or worse
Hgb < 9
Use of anti-resorptive agent
non-English speaking
Bone metastasis

Study is for people with:

Prostate Cancer

Estimated Enrollment:

19

Study ID:

NCT03386812

Recruitment Status:

Completed

Sponsor:

University of Texas Southwestern Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UT Southwestern
Dallas Texas, 75390, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

19

Study ID:

NCT03386812

Recruitment Status:

Completed

Sponsor:


University of Texas Southwestern Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider